Why ResMed (RMD) is Poised to Beat Earnings Estimates Again

Posted byZacks Equity Research Leave a comment on Why ResMed (RMD) is Poised to Beat Earnings Estimates Again

ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Leave a comment

Your email address will not be published. Required fields are marked *